Marchetti explains the benefits of assessing RV/TLC rather than absolute RV to determine the efficacy of BLVR in patients with emphysema and hyperinflation.
Nathaniel Marchetti, DO
Advertisement
Nathaniel Marchetti, DO, is a professor of thoracic medicine and surgery at Lewis Katz School of Medicine at Temple University and medical director of the respiratory intensive care unit at Temple University Hospital.
Articles by Nathaniel Marchetti, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
2
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
3
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
4
What Are the Side Effects of Hair and Skin Supplements in Dermatology? With Rajani Katta, MD
5